World Congress on Pharmaceutical Chemistry and Drug Development

  19 Sep 2024 - 20 Sep 2024

   Paris, France

conference-img

World Congress on Pharmaceutical Chemistry and Drug Development

19 Sep 2024

 - 

20 Sep 2024

Paris, France



Join the prestigious World Congress on Pharmaceutical Chemistry and Drug Development (WCPD 2024) to explore global challenges and advancements in pharmaceutics. Engage with renowned speakers, network with industry leaders, and contribute to shaping the future of pharmaceutical science.

Explore cutting-edge advancements in pharmaceutics at WCPD 2024, featuring renowned speakers, networking opportunities, and workshops. Join to shape the future of pharmaceutical chemistry and drug development.

International Cancer Conference

On: 15 Oct 2026

-

15 Oct 2026


Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

On: 20 Oct 2026

-

20 Oct 2026


International Conference on Healthcare Innovation and Medical Sciences (ICHIMS)

On: 15 Nov 2026

-

15 Nov 2026


International Conference on Medical, Biological and Pharmaceutical Sciences

On: 15 Nov 2026

-

15 Nov 2026


Summer Global Neuroscience & Neurology Symposium

On: 15 Nov 2026

-

15 Nov 2026


International Cancer Conference

On: 15 Oct 2026

-

15 Oct 2026


Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

On: 20 Oct 2026

-

20 Oct 2026


International Conference on Healthcare Innovation and Medical Sciences (ICHIMS)

On: 15 Nov 2026

-

15 Nov 2026


International Conference on Medical, Biological and Pharmaceutical Sciences

On: 15 Nov 2026

-

15 Nov 2026


Summer Global Neuroscience & Neurology Symposium

On: 15 Nov 2026

-

15 Nov 2026



Whats more on Hidoc Dr.


Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Advances in "next generation" photoactive cancer therapy

2.

Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCL

3.

The American College of Physicians updated its recommendations for colorectal cancer screening.

4.

Optimizing Sequencing of BCMA-Directed Therapies in Myeloma

5.

According to a study, patients with ovarian cancer who undergo aggressive surgery have a 70% lower chance of dying.

Recommended News For You

Conferences That Might Interest You

Recommended Articles For You

Boost Your Knowledge With These Quizzes





© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot